Sedative load and anticholinergic burden among older adults in Slovenia over a decade: Potential for optimization of pharmacotherapy
暂无分享,去创建一个
[1] S. Hilmer,et al. The anticholinergic burden: from research to practice , 2022, Australian prescriber.
[2] T. Strandberg,et al. Temporal Trends Over Two Decades in the Use of Anticholinergic Drugs Among Older Community-Dwelling People in Helsinki, Finland , 2022, Drugs & Aging.
[3] I-Chia Chien,et al. Trends, correlates, and disease patterns of sedative-hypnotic use among elderly persons in Taiwan , 2022, BMC Psychiatry.
[4] C. Lunghi,et al. Trends in benzodiazepine and alternative hypnotic use in relation with multimorbidity among older adults in Quebec, Canada , 2021, Pharmacoepidemiology and drug safety.
[5] J. Turgeon,et al. Quantifying Anticholinergic Burden and Sedative Load in Older Adults with Polypharmacy: A Systematic Review of Risk Scales and Models , 2021, Drugs & Aging.
[6] R. Marioni,et al. Increase in anticholinergic burden from 1990 to 2015: Age‐period‐cohort analysis in UK biobank , 2021, British journal of clinical pharmacology.
[7] Y. Bao,et al. Anticholinergic drugs and the risk of dementia: A systematic review and meta-analysis , 2021, Neuroscience & Biobehavioral Reviews.
[8] Y. Loke,et al. Interventions to Reduce Anticholinergic Burden in Adults Aged 65 and Older: A Systematic Review. , 2020, Journal of the American Medical Directors Association.
[9] B. Hanratty,et al. Adverse Outcomes of Polypharmacy in Older People: Systematic Review of Reviews. , 2020, Journal of the American Medical Directors Association.
[10] H. Kautiainen,et al. Temporal Trends in the Use of Anticholinergic Drugs Among Older People Living in Long-Term Care Facilities in Helsinki , 2019, Drugs & Aging.
[11] H. Kautiainen,et al. Fourteen-Year Trends in the Use of Psychotropic Medications, Opioids, and Other Sedatives Among Institutionalized Older People in Helsinki, Finland. , 2019, Journal of the American Medical Directors Association.
[12] M. Lapeyre-Mestre,et al. Trends of atropinic (anticholinergic) exposure in the elderly: a 10‐year analysis in the French EGB database , 2019, Fundamental & clinical pharmacology.
[13] Mitja Kos,et al. Introduction of therapeutic reference pricing in Slovenia and its economic consequences , 2018, The European Journal of Health Economics.
[14] I. Locatelli,et al. Clinically relevant potential drug–drug interactions among outpatients: A nationwide database study , 2017, Research in social & administrative pharmacy : RSAP.
[15] S. Marcus,et al. National Trends in Antidepressant, Benzodiazepine, and Other Sedative-Hypnotic Treatment of Older Adults in Psychiatric and Primary Care. , 2017, The Journal of clinical psychiatry.
[16] M. Boustani,et al. Association of Anticholinergic Burden with Cognitive Impairment and Health Care Utilization Among a Diverse Ambulatory Older Adult Population , 2016, Pharmacotherapy.
[17] Christopher N. Kaufmann,et al. Trends in prescribing of sedative‐hypnotic medications in the USA: 1993–2010 , 2016, Pharmacoepidemiology and drug safety.
[18] T. Chen,et al. Health Care Practitioners’ Perspectives on Deprescribing Anticholinergic and Sedative Medications in Older Adults , 2016, The Annals of pharmacotherapy.
[19] P. Rochon,et al. Changing Pattern of Sedative Use in Older Adults: A Population-Based Cohort Study , 2016, Drugs & Aging.
[20] J. Bell,et al. Eight-Year Trends in the Use of Opioids, Other Analgesics, and Psychotropic Medications Among Institutionalized Older People in Finland. , 2015, Journal of the American Medical Directors Association.
[21] R. Kenny,et al. Sedative load and frailty among community-dwelling population aged ≥65 years. , 2015, Journal of the American Medical Directors Association.
[22] S. Duffull,et al. Anticholinergic burden quantified by anticholinergic risk scales and adverse outcomes in older people: a systematic review , 2015, BMC Geriatrics.
[23] H. Aljadhey,et al. A systematic review of hospitalization resulting from medicine‐related problems in adult patients , 2014, British journal of clinical pharmacology.
[24] Maria C. Pruchnicki,et al. Evaluation of anticholinergic burden of medications in older adults. , 2013, Journal of the American Pharmacists Association : JAPhA.
[25] M. Boustani,et al. The 2012 update to the anticholinergic cognitive burden scale , 2013 .
[26] R. V. Vander Stichele,et al. Systematic review of anticholinergic risk scales in older adults , 2013, European Journal of Clinical Pharmacology.
[27] F. Blyth,et al. High risk prescribing in older adults: prevalence, clinical and economic implications and potential for intervention at the population level , 2013, BMC Public Health.
[28] R. Sulkava,et al. Sedative Load Among Community-Dwelling People Aged 75 Years or Older: Association With Balance and Mobility , 2012, Journal of clinical psychopharmacology.
[29] R. Sulkava,et al. Sedative Load among Community-Dwelling People Aged 75 Years and Older , 2011, Drugs & aging.
[30] C. Goodman,et al. Sedative load of medications prescribed for older people with dementia in care homes , 2011, BMC geriatrics.
[31] Cornelius Katona,et al. Anticholinergic Medication Use and Cognitive Impairment in the Older Population: The Medical Research Council Cognitive Function and Ageing Study , 2011, Journal of the American Geriatrics Society.
[32] M. Boustani,et al. Impact of anticholinergics on the aging brain: a review and practical application , 2008 .
[33] S. Kivelä,et al. A model to classify the sedative load of drugs , 2003, International journal of geriatric psychiatry.
[34] THE WORLD HEALTH ORGANIZATION , 1954 .
[35] J. Bell,et al. Anticholinergic and sedative medicines - prescribing considerations for people with dementia. , 2012, Australian family physician.